Unknown PHASE4 INTERVENTIONAL 4-arm
NCT01866566
The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Phase 4 Study of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Sponsor: Beijing Center for Disease Control and Prevention
Conditions
Varicella
Interventions
HBV-3 HBV-6 varicella-3 varicella-6
Updated 1 time since 2024 Last updated: Jun 25, 2013 Started: Jun 30, 2013 Primary completion: Jan 31, 2014 Completion: Jan 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT01866566, this PHASE4 trial focuses on Varicella and remains ongoing. Sponsored by Beijing Center for Disease Control and Prevention, it has been updated 1 time since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Unknown — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Beijing Center for Disease Control and Prevention
Data source: Beijing Center for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .